163798-87-6

Basic information

• Product Name: tert-butyl 2-(chloromethyl)-1H-benzimidazole-1-carboxylate
• Synonyms: tert-butyl 2-(chloromethyl)-1H-benzimidazole-1-carboxylate;1-(tert-Butoxycarbonyl)-2-(chloromethyl)-benzimidazole;tert-butyl 2-(chloroMethyl)-1H-benzo[d]iMidazole-1-carboxylate;1H-BenziMidazole-1-carboxylic acid, 2-(chloroMethyl)-, 1,1-diMethylethyl ester
• CAS NO: 163798-87-6
• Molecular Formula: C₁₃H₁₅ClN₂O₂
• Molecular Weight: 266.7234
• Mol File: 163798-87-6.mol

Chemical Properties

• Boiling Point: 377.6±44.0 °C(Predicted)
• Appearance: /
• Density: 1.23±0.1 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 2.01±0.10(Predicted)
• CAS DataBase Reference: tert-butyl 2-(chloromethyl)-1H-benzimidazole-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 2-(chloromethyl)-1H-benzimidazole-1-carboxylate(163798-87-6)
• EPA Substance Registry System: tert-butyl 2-(chloromethyl)-1H-benzimidazole-1-carboxylate(163798-87-6)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 163798-87-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
Tert-butyl 2-(chloromethyl)-1H-benzimidazole-1-carboxylate is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs. Its unique structure allows for the creation of a wide range of medicinal compounds.
Used in Agrochemical Production:
In the agrochemical industry, tert-butyl 2-(chloromethyl)-1H-benzimidazole-1-carboxylate is utilized as an intermediate in the production of various agrochemicals, contributing to the development of effective solutions for agricultural applications.
Used in Medicinal Chemistry Research:
Tert-butyl 2-(chloromethyl)-1H-benzimidazole-1-carboxylate is used as a research compound in medicinal chemistry, particularly for its potential as an anti-cancer agent. Its unique properties are being studied to explore its effectiveness in combating cancer cells.
Used in Organic Chemistry:
As a versatile compound in organic chemistry, tert-butyl 2-(chloromethyl)-1H-benzimidazole-1-carboxylate is employed in various chemical reactions and processes, showcasing its potential value in advancing the field of organic chemistry.

Upstream product

• 4857-04-9 2-chloromethyl-1H-benzimidazole 
• 24424-99-5 di-tert-butyl dicarbonate 
• 95-54-5 1,2-diamino-benzene 

Downstream Products

• 1279695-05-4 C₂₄H₂₇N₅ 
• 1442637-92-4 C₃₃H₄₁N₃O₂S₂ 
• 558447-26-0 AMD₀₇₀ 
• 98997-01-4 2-(methylaminomethyl)benzimidazole 
• 305357-42-0 ethyl 4-O-allyl-3,4-dihydroxybenzoate 
• 1057447-16-1 N-((1H-benzo[d]imidazol-2-yl)methyl)-N-benzyl-4-((benzylamino)-methyl)benzenesulfonamide trifluoroacetate 
• 1059145-41-3 4-((((1H-benzo[d]imidazol-2-yl)methyl)(5,6,7,8-tetrahydroquinolin-8-yl)amino)methyl)-N'-phenylbenzohydrazide 

Relevant articles and documents

Compositions of CXCR4 inhibitors and methods of preparation and use

The present invention provides compositions and methods of use for treating, preventing, or ameliorating a disease, disorder, or condition associated with a chemokine receptor such as CXCR4.

TRANSGLUTAMINASE 2 (TG2) INHIBITORS

Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit transglutaminase 2 (TG2). Also described herein are methods for using such TG2 inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from TG2 inhibition.

Multi-substituted amine compound and its preparation and use (by machine translation)

The invention belongs to the field of medical technology, in particular, the present invention provides the following formula I shown multi-substituted amine compound or its isomer or its pharmaceutically acceptable salt, ester, prodrug or hydrate, its pharmaceutical composition, preparation method thereof and its use in the preparation of medicine for treating aids in use. The compound or pharmaceutical composition containing the compound can be used as an inhibitor for inhibiting HIV integrase with LEDGF/p75 between protein - protein interaction and HIV integrase dimerization, then can be used for the treatment of aids. . (by machine translation)

NOVEL FERROPORTIN INHIBITORS

The invention relates to novel ferroportin inhibitors of the general formula (I) pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia and hemochromatosis.

PIPERIDINONES USEFUL IN THE TREATMENT OF INFLAMMATION

There is provided compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, m and n have meanings given in the description, and pharmaceutically acceptable derivatives thereof, which compounds are useful in the treatment of diseases and conditions associated with inflammation.

AMD070, a CXCR4 chemokine receptor antagonist: Practical large-scale laboratory synthesis

An efficient and convergent four-step synthetic route to the CXCR4 chemokine receptor antagonist AMD070 (1) has been developed which employs only a single chromatographic step in the entire sequence. Novel reductive amination methods have been developed for the coupling of 2 and 3 in which a dehydrative imine formation is followed by reduction with an attenuated borohydride reagent (zinc chloride and sodium borohydride). Selective extraction methods were employed to purify synthetic intermediates and remove reagents and impurities. A procedure has also been developed to isolate 1 in a pure crystalline form.

CHEMOKINE RECEPTOR MODULATORS

The invention provides compounds of Formula (I) and pharmaceutical composi tions comprising compounds of Formula (I). These compounds are useful treating or preventing HIV infections, and in treating proliferative disorders such as inhibiting the metastasis of various cancers

CHEMICAL COMPOUNDS

The present invention provides compounds of Formula (I) comprising: including salts, solvates, and physiologically functional derivatives thereof, pharmaceutical formulations containing them, processes for their preparation, and methods of treatment using them.

Benzimidazole compounds and antiviral uses thereof

The present invention relates to novel benzimidazole compounds that have useful antiviral activity. More specifically, the invention encompasses benzimidazole compounds that inhibit membrane fusion associated events such as viral transmission, reduce vira

Catechols as antimicrobial agents

Compounds, pharmaceutically acceptable salts, and compositions thereof of the general formula: wherein Ar is aryl and heteroaryl; R1, R2, R3, and R4are hydrido, alkyl, cyano, heteroaryl, hydroxy, amino, acylamino, halo, alkoxy, aryloxy, carboxyamido, alkenyl, cycloalkyl, heterocyclyl, acyl, acyloxy, carboalkoxy, carboxy, thio, sulfinyl, sulfonyl and sulfoxy, R5, R6, R7, and R8are hydrido and lower alkyl; and Het is a nitrogen-containing heterocyclic ring.